Literature DB >> 17484943

Depression, anxiety and quality of life in a chronic lymphocytic leukemia cohort.

Tomer T Levin1, Yuelin Li, John Riskind, Kanti Rai.   

Abstract

OBJECTIVE: Although chronic lymphocytic leukemia (CLL) accounts for 25-30% of leukemia cases, little is known about its psychosocial correlates. This study examines anxiety, depression and quality of life (QOL) in a CLL cohort.
METHODS: One hundred five patients recruited from a CLL research database were classified into two groups: "watch and wait" or active treatment. The patients completed a mail-in battery of depression, anxiety and QOL measures.
RESULTS: There was no statistical difference between depression, anxiety and physical/mental QOL in "watch and wait" versus active-treatment groups. Patients < or =60 years reported more depression (P=.014) and worse emotional (P=.0001) and social QOL (P=.002). They also had more "watch and wait" anxiety (P=.052). Social and emotional QOL were similar in both newly diagnosed patients and those diagnosed >6 years ago, although physical QOL worsens with time (P=.05).
CONCLUSION: Depression, anxiety and QOL are remarkably similar in "watch and wait" versus actively treated CLL, despite the latter group having, by definition, later stage disease. Patients < or =60 years are more depressed and have reduced emotional and social QOL. Younger "watch and wait" patients are more anxious. Patients diagnosed for more than 6 years have a worse physical QOL, but their social and emotional QOL are similar to those of newly diagnosed patients.

Entities:  

Mesh:

Year:  2007        PMID: 17484943     DOI: 10.1016/j.genhosppsych.2007.01.014

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  16 in total

1.  Cells, cytokines, chemokines, and cancer stress: A biobehavioral study of patients with chronic lymphocytic leukemia.

Authors:  Barbara L Andersen; Neha Godiwala Goyal; David M Weiss; Travis D Westbrook; Kami J Maddocks; John C Byrd; Amy J Johnson
Journal:  Cancer       Date:  2018-05-14       Impact factor: 6.860

2.  Identifying risk factors for depression and anxiety symptoms in patients with chronic lymphocytic leukemia.

Authors:  Abigail S Robbertz; David M Weiss; Farrukh T Awan; John C Byrd; Kerry A Rogers; Jennifer A Woyach
Journal:  Support Care Cancer       Date:  2019-07-22       Impact factor: 3.603

3.  Influence of Pain and Analgesia on Cancer Research Studies.

Authors:  Douglas K Taylor
Journal:  Comp Med       Date:  2019-07-17       Impact factor: 0.982

4.  Differential Expressions of p53, p53R2, hRRM2 and PBR in Chronic Lymphocytic Leukemia: A Correlation with Intracellular Cholesterol.

Authors:  Ankit Verma; N C Chandra
Journal:  Indian J Clin Biochem       Date:  2015-12-16

Review 5.  Economic Burden and Quality-of-Life Effects of Chronic Lymphocytic Leukemia: A Systematic Review of the Literature.

Authors:  Simon Frey; Carl R Blankart; Tom Stargardt
Journal:  Pharmacoeconomics       Date:  2016-05       Impact factor: 4.981

6.  Illness Perceptions in Chronic Lymphocytic Leukemia: Testing Leventhal's Self-regulatory Model.

Authors:  Travis D Westbrook; Eleshia J Morrison; Kami J Maddocks; Farrukh T Awan; Jeffrey A Jones; Jennifer A Woyach; Amy J Johnson; John C Byrd; Barbara L Andersen
Journal:  Ann Behav Med       Date:  2019-08-16

7.  Worsening Quality of Life in Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients in Active Surveillance: A 12-Month Longitudinal Study.

Authors:  Kelly M Trevino; Peter Martin; Zhengming Chen; John P Leonard
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2021-08-12

8.  Individual differences in physical symptom burden and psychological responses in individuals with chronic lymphocytic leukemia.

Authors:  Eleshia J Morrison; Joseph M Flynn; Jeffrey Jones; John C Byrd; Barbara L Andersen
Journal:  Ann Hematol       Date:  2016-08-19       Impact factor: 4.030

9.  Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity.

Authors:  Shelly Inbar; Elad Neeman; Roi Avraham; Marganit Benish; Ella Rosenne; Shamgar Ben-Eliyahu
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

10.  Health related quality of life in a nationally representative sample of haematological patients.

Authors:  Anna T Johnsen; Dorte Tholstrup; Morten Aa Petersen; Lise Pedersen; Mogens Groenvold
Journal:  Eur J Haematol       Date:  2009-03-05       Impact factor: 2.997

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.